← Leaderboards
Dhimant Harkisan Desai
Pennsylvania State Univ Hershey Med Ctr
$307,386
Attributed
$307,386
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $77.2K · FY2009–15$100K$75K$50K$25K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$307,386 · 2
By mechanism
R03$307,386 · 2
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Neil D Christensen$4,364,737
- Joshua E Muscat$12,593,056
- Jonathan Foulds$10,738,186
- Dongxiao Sun$2,338,189
- Charles H. Lang$16,686,500
Others in their field
Top investigators on “Inhibitor/Antagonist”
- John M Lachin · George Washington University$117,867,649
- David M Nathan · Massachusetts Institute Of Technology$117,867,649
- Randall J Bateman · Washington University$110,978,751
- David Heimbrook · Leidos Biomedical Research, Inc.$72,139,282
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Walter John Curran · Thomas Jefferson University$32,790,605
Research focus
Inhibitor/AntagonistMaximum Tolerated DoseColon CarcinomaInbred F344 RatsMalignant - DescriptorMalignant NeoplasmsChemopreventionClinical TrialsDiagnosisFutureLesionMaleAnalogBaseCellsCessation Of LifeCancer CellChemopreventive AgentColonic NeoplasmsColorectal CancerDietEffective InterventionAberrant Crypt FociMicronutrients
Grant awards (4)
Chemoprevention of colon cancer by a novel COX-2 inhibitor$76,500
R03 · FY2015 · CA · contact PI
Chemoprevention of colon cancer by a novel COX-2 inhibitor$76,500
R03 · FY2014 · CA · contact PI
iNOS/Akt Inhibotor for Colon Cancer Chemoprevention$77,186
R03 · FY2010 · CA · contact PI
iNOS/Akt Inhibotor for Colon Cancer Chemoprevention$77,200
R03 · FY2009 · CA · contact PI